A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Apatinib Mesylate Tablets;   Drug: Tegafur Gimeracil Oteracil Potassium Capsules
Sponsor:   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not yet recruiting - verified March 2017

http://ift.tt/2olmfSh